Single cell whole genome sequencing reveals that NFKB1 mutation affects radiotherapy sensitivity in cervical cancer

Oncotarget
Dong YangWenjing Hao

Abstract

Cervical cancer is the third most common cancer in women. Radiotherapy resistance remains a major obstacle for patients with cervical cancer. Somatic alterations in human genomes are responsible for radiotherapy resistance. Here, we performed single cell whole genome sequencing on 13 cells before radiotherapy and 12 cells after radiotherapy from a Chinese woman patient with cervical carcinoma. We identified one damaging mutation in NFKB1 (G430E), which showed significantly increased mutant allele frequency after radiotherapy than that before radiotherapy. Further functional assays showed that NFKB1 was a tumour suppressor in cervical cancer by inhibiting cell proliferation, colony formation and migration, while the mutation in NFKB1 could weaken the tumour suppressing functions of NFKB1. NFKB1 enhanced the sensitivity of cervical cancer cells to the effects of irradiation, and the mutation in NFKB1 weakened this effect. These results suggested that NFKB1 may be a potential molecular target in cervical cancer radiation therapy in the future.

References

Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Mar 29, 2002·Journal of Clinical Pathology·F X BoschK V Shah
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kate Cuschieri, Nicolas Wentzensen
Nov 26, 2009·Biochimica Et Biophysica Acta·Andriy Marusyk, Kornelia Polyak
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Uri TaboriCynthia Hawkins
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 15, 2011·Nature·Nicholas NavinMichael Wigler
Jul 21, 2011·British Journal of Cancer·K J HarringtonT Illidge
Feb 3, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlos L Arteaga, José Baselga
Mar 23, 2012·Immunological Reviews·Joseph A DiDonatoMichael Karin
Jul 31, 2013·Nature Reviews. Genetics·Ehud ShapiroSten Linnarsson
Nov 19, 2013·Trends in Pharmacological Sciences·Jessica L Esseltine, John D Scott
Jan 7, 2014·Nature·Akinyemi I OjesinaMatthew Meyerson
Jan 15, 2014·International Journal of Radiation Oncology, Biology, Physics·Kari TanderupPerry W Grigsby
Jun 4, 2014·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Apr 17, 2015·Nature Communications·C L WilsonD A Mann

❮ Previous
Next ❯

Citations

Mar 27, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xue BaiZhiwei Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
single cell sequencing
single-cell sequencing
exome sequencing
transfection

Software Mentioned

R
PolyPhen2
SIFT
Burrows Aligner
VarScan

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.